-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Axsome Therapeutics, Raises Price Target to $316

Benzinga·08/12/2026 12:49:11
语音播报
Mizuho analyst Graig Suvannavejh maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and raises the price target from $306 to $316.